(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-23 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1765270
Date | Daily Closing Price | Open | High | Low | Volume |
23 Fri Aug 2024 | 1.21 | 1.16 | 1.23 | 1.16 | 0.597 times |
22 Thu Aug 2024 | 1.17 | 1.19 | 1.26 | 1.17 | 0.766 times |
21 Wed Aug 2024 | 1.19 | 1.08 | 1.19 | 1.08 | 1.077 times |
20 Tue Aug 2024 | 1.06 | 1.11 | 1.13 | 1.02 | 1.174 times |
19 Mon Aug 2024 | 1.08 | 1.08 | 1.09 | 1.05 | 0.644 times |
16 Fri Aug 2024 | 1.08 | 1.09 | 1.09 | 1.04 | 0.519 times |
15 Thu Aug 2024 | 1.09 | 1.08 | 1.09 | 1.05 | 0.541 times |
14 Wed Aug 2024 | 1.04 | 1.06 | 1.08 | 1.00 | 0.816 times |
13 Tue Aug 2024 | 1.05 | 1.11 | 1.15 | 1.04 | 1.115 times |
12 Mon Aug 2024 | 1.09 | 1.08 | 1.19 | 1.04 | 2.496 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 1.2, but if it comes below 1.2, then a intra day sell could be more profitable.
If you take a sell trade below 1.2, then use 1.2 as stoploss and 1.12 as target. However if you take a buy trade in stock , then use 1.2 as stoploss and 1.4 as target.
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.83 |
Downside Target | 0.87 |
Downside Target | 0.94 |
Downside Target | 0.98 |
Downside Target | 1.00 |
Downside Target | 1.02 |
Downside Target | 1.08 |
Downside Target | 1.15 |
Downside Target | 1.19 |
Upside Target | 1.26 |
Upside Target | 1.34 |
Upside Target | 1.42 |
Upside Target | 1.48 |
Upside Target | 1.55 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 1.07 |
Downside Intraday Target | 0.92 |
Upside Intraday Target | 1.31 |
Upside Intraday Target | 1.4 |
Downside Intraday Target | 1.16 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
23 Fri Aug 2024 | 1.21 | 1.08 | 1.26 | 1.02 | 0.776 times |
16 Fri Aug 2024 | 1.08 | 1.08 | 1.19 | 1.00 | 0.887 times |
09 Fri Aug 2024 | 0.99 | 1.04 | 1.08 | 0.94 | 0.458 times |
02 Fri Aug 2024 | 1.17 | 1.43 | 1.48 | 1.04 | 2.992 times |
26 Fri Jul 2024 | 1.39 | 1.20 | 1.42 | 1.16 | 0.976 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
23 Fri Aug 2024 | 1.21 | 1.33 | 1.36 | 0.94 | 1.041 times |
31 Wed Jul 2024 | 1.33 | 1.00 | 1.48 | 0.98 | 1.232 times |
28 Fri Jun 2024 | 0.97 | 1.10 | 1.15 | 0.83 | 0.953 times |
31 Fri May 2024 | 1.13 | 1.19 | 1.34 | 1.00 | 1.279 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.1 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.1 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.